HR941-117 · 117th Congress
Signed into Law
Signed May 26, 2021TRANSPLANT Act of 2021
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and…
VOTE BREAKDOWN
Final passage · 287 politicians tracked
279
YEA
2
NAY
0
PRESENT
6
NOT VOTING
97% YEA1% NAY
BY PARTY
DEMOCRAT142 YEA · 0 NAY
100%
REPUBLICAN137 YEA · 2 NAY
94%
MONEY ON THIS BILL
Top donor industries among YEA voters vs NAY voters · lobbying activity in affected industries
⬆ YEA voters — top donor industries
- 1. Party & Leadership3948 pts
- 2. Labor Unions2721 pts
- 3. Single-Issue Advocacy2520 pts
⬇ NAY voters — top donor industries
- 1. Party & Leadership119 pts
- 2. Single-Issue Advocacy41 pts
- 3. Securities & Investment7 pts
◎ Lobbying activity by issue area
No bill-issue lobbying matches.
“Pts” = sum of per-member industry donation scores (% of total donations from that industry, summed across the group). Higher means that industry funds a larger share of contributions for that voting bloc.
INDIVIDUAL VOTES
Recorded positions for tracked politicians
SPONSORS
Doris O. Matsui
D-CA · Primary
14 COSPONSORS
BIPARTISAN